📰 Abt News
Page 114 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
August 20, 2023
Arcblock (ABT) traded 14.6% higher against the U.S. dollar during the one day period ending at 20:00 PM ET on August 19th. Arcblock has a total market cap of $8.46 million and $442,668.02 worth of Arcblock was traded on exchanges in the last day. One Arcblock token can now be bought for about $0.0859 or […]
August 19, 2023
Heritage Financial Services LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,965 shares of the healthcare product maker’s stock after selling 110 shares during the period. […]
August 19, 2023
Oppenheimer Asset Management Inc. reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 254,782 shares of the healthcare product maker’s stock after selling 12,616 shares during the quarter. Oppenheimer Asset Management […]
August 19, 2023
Heritage Financial Services LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,965 shares of the healthcare product maker’s stock after selling 110 shares during the period. […]
August 19, 2023
Burney Co. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,142 shares of the healthcare product maker’s stock after selling 2,403 shares during the period. Burney Co.’s holdings in Abbott Laboratories […]
August 19, 2023
Oppenheimer Asset Management Inc. lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 254,782 shares of the healthcare product maker’s stock after selling 12,616 shares during the period. Oppenheimer Asset Management Inc.’s […]
August 18, 2023
Delaney Dennis R boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 42,154 shares of the healthcare product maker’s stock after buying an additional 385 shares during the quarter. Abbott Laboratories makes […]
August 18, 2023
Cerro Pacific Wealth Advisors LLC boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 28.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,876 shares of the healthcare product maker’s stock after purchasing an additional 3,714 shares […]
August 18, 2023
Delaney Dennis R increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,154 shares of the healthcare product maker’s stock after acquiring an additional 385 shares during the […]
August 18, 2023
Allstate Corp lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 90.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,922 shares of the healthcare product maker’s stock after selling 62,362 shares during the period. Allstate Corp’s […]